Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cholangiocarcinoma × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 35 Neoplasms 18 Breast Neoplasms 18 Fatigue 9 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Lung Neoplasms 4 Hematologic Neoplasms 4 Obesity 3 Weight Loss 2 Smoking 2 Sedentary Behavior 2 Postoperative Complications 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Mixed Cancer 2 Lymphedema 2 Frailty 2 Colonic Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urologic Neoplasms 1 Urinary Incontinence 1 Stomach Neoplasms 1 Sarcoma 1 Risk Reduction Behavior 1 Rehabilitation After Lung Cancer Surgery 1

Interventions

Gemcitabine 12 Oxaliplatin 8 Capecitabine 6 apatinib 5 tislelizumab 4 Radiofrequency Ablation 4 Fluorouracil 4 Cisplatin 4 sintilimab 3 lenvatinib 3 Surgical Procedures, Operative 3 Neoadjuvant Therapy 3 Leucovorin 3 Irinotecan 3 toripalimab 2 regorafenib 2 pembrolizumab 2 camrelizumab 2 Stents 2 Radiotherapy 2 Photochemotherapy 2 Immunotherapy 2 Hepatectomy 2 Folfox protocol 2 Everolimus 2 Cholangiopancreatography, Endoscopic Retrograde 2 Blood Specimen Collection 2 surufatinib 1 pemigatinib 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02162914 2020-07-31

REACHIN

Erasme University Hospital

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡